These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1870559)

  • 21. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
    Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-resistant tuberculosis in HIV-infected persons: Italy 1999-2000.
    Vanacore P; Koehler B; Carbonara S; Zacchini F; Bassetti D; Antonucci G; Ippolito G; Girardi E;
    Infection; 2004 Dec; 32(6):328-32. PubMed ID: 15597221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nosocomial tuberculosis in the AIDS era with an emphasis on multidrug-resistant disease.
    Snider DE; Dooley SW
    Heart Lung; 1993; 22(4):365-9. PubMed ID: 8360070
    [No Abstract]   [Full Text] [Related]  

  • 25. Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):253-6. PubMed ID: 19300407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for nosocomial transmission of multidrug-resistant tuberculosis due to Mycobacterium bovis among HIV-infected patients.
    Cobo J; Asensio A; Moreno S; Navas E; Pintado V; Oliva J; Gómez-Mampaso E; Guerrero A
    Int J Tuberc Lung Dis; 2001 May; 5(5):413-8. PubMed ID: 11336271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nosocomial transmission of Mycobacterium tuberculosis in a children's hospital.
    Lee EH; Graham PL; O'Keefe M; Fuentes L; Saiman L
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):689-92. PubMed ID: 15971399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis.
    Portugal I; Covas MJ; Brum L; Viveiros M; Ferrinho P; Moniz-Pereira J; David H
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):207-13. PubMed ID: 10094321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The "new tuberculosis" and its changing epidemiology. Nosocomial transmission and hospital discharge standards.
    Blumberg HM
    J Med Assoc Ga; 1995 May; 84(5):209-14. PubMed ID: 7782706
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.
    Frieden TR; Munsiff SS; Ahuja SD
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):116. PubMed ID: 17217141
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-resistant tuberculosis: etiology, management and prevention.
    O'Brien RJ
    Semin Respir Infect; 1994 Jun; 9(2):104-12. PubMed ID: 7973169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
    Fujiwara PI; Cook SV; Rutherford CM; Crawford JT; Glickman SE; Kreiswirth BN; Sachdev PS; Osahan SS; Ebrahimzadeh A; Frieden TR
    Arch Intern Med; 1997 Mar; 157(5):531-6. PubMed ID: 9066457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium tuberculosis transmission in a newborn nursery and maternity ward--New York City, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(50):1280-3. PubMed ID: 16371943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reducing the risk of tuberculosis transmission.
    Allen G
    Nurs Manage; 1994 May; 25(5):80Q, 80T, 80W. PubMed ID: 8196891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital.
    Weltman AC; Rose DN
    Arch Intern Med; 1994 Oct; 154(19):2161-7. PubMed ID: 7944836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis control in hospitals. Technical Panel on Infections within Hospitals, American Hospital Association.
    World Hosp; 1992; 28(2):11-4. PubMed ID: 10128751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.
    Hongthiamthong P; Chuchottaworn C; Amatayakul N
    J Med Assoc Thai; 1994 Jul; 77(7):363-7. PubMed ID: 7876754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.